Evaluation of the relationship between endometrial thickness and failure of single-dose methotrexate in ectopic pregnancy

被引：16

作者：

Takacs P. ^{[1
]}

Chakhtoura N. ^{[1
]}

De Santis T. ^{[1
]}

Verma U. ^{[1
]}

机构：

[1] Department of Obstetrics and Gynecology, Jackson Memorial Hospital, University of Miami School of Medicine, Miami, FL 33010

来源：

Archives of Gynecology and Obstetrics | 2005年 / 272卷 / 4期

关键词：

Ectopic pregnancy; Endometrial stripe; Methotrexate;

D O I：

10.1007/s00404-005-0009-y

中图分类号：

学科分类号：

摘要：

Objective: To test the hypothesis that endometrial stripe thicker than 12 mm increases treatment failure of single-dose methotrexate for the management of ectopic pregnancy. Study design: Seventy-three patients with ectopic pregnancy and measured pretreatment endometrial stripe were divided into two groups based on the endometrial stripe thickness (>12 mm or ≤ 12 mm). All patients were candidates for single-dose methotrexate treatment. Variables analyzed between the two groups were endometrial stripe thickness, initial beta human chorionic gonadotropin level (hCG), size of the ectopic mass, presence of fetal heart tones, previous ectopic pregnancy, and clinical outcomes. Results: Sixty patients had endometrial stripe thickness ≤ 12 mm and 13 patients >12 mm. The two groups were similar in initial hCG, size of ectopic mass, presence of fetal heart tones and rate of previous ectopic pregnancy. The failure rate was significantly higher in the group with endometrial stripe >12 mm compared to the group ≤ 12 mm (n=7, 53% vs. n=3, 5%, P<0.01). The endometrial stripe was significantly thicker in the group with endometrial stripe thickness >12 mm compared to the group ≤ 12 mm (mean ± SD, 17.64±5.82 mm vs. 7.69±2.82 mm, P<0.01). Conclusion: Endometrial stripe thicker than 12 mm increases the risk for treatment failure with single-dose methotrexate. © Springer-Verlag 2005.

引用

页码：269 / 272

页数：3

共 18 条

[1]

Alshimmiri M.M., Al-Saleh E.A., Al-Harmi J.A., AlSalili M.B., Adwani A.A., Ibrahim M.E., Treatment of ectopic pregnancy with a single intramuscular dose of methotrexate, Arch Gynecol Obstet, 268, pp. 181-183, (2003)

[2]

Barnhart K., Esposito M., Coutifaris C., An update on the medical treatment of ectopic pregnancy, Obstet Gynecol Clin North Am, 27, pp. 653-667, (2000)

[3]

Corsan G.H., Karacan M., Qasim S., Bohrer M.K., Ransom M.X., Kemmann E., Identification of hormonal parameters for successful systemic single-dose methotrexate therapy in ectopic pregnancy, Hum Reprod, 10, pp. 2719-2722, (1995)

[4]

Da Costa Soares R., Elito Jr. J., Han K.K., Camano L., Endometrial thickness as an orienting factor for the medical treatment of unruptured tubal pregnancy, Acta Obstet Gynecol Scand, 83, pp. 289-292, (2004)

[5]

Erdem M., Erdem A., Arslan M., Oc A., Biberoglu K., Gursoy R., Single-dose methotrexate for the treatment of unruptured ectopic pregnancy, Arch Gynecol Obstet, 270, pp. 201-204, (2004)

[6]

Laibl V., Takacs P., Kang J., Previous ectopic pregnancy as a predictor of methotrexate failure, Int J Gynaecol Obstet, 85, pp. 177-178, (2004)

[7]

Levgur M., Tsai T., Kang K., Feldman J., Kory L.A., Endometrial stripe thickness in tubal and intrauterine pregnancies, Fertil Steril, 74, pp. 889-891, (2000)

[8]

Lipscomb G.H., Bran D., McCord M.L., Portera J.C., Ling F.W., Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate, Am J Obstet Gynecol, 178, pp. 1354-1358, (1998)

[9]

Lipscomb G.H., McCord M.L., Stovall T.G., Huff G., Portera S.G., Ling F.W., Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies, N Engl J Med, 341, pp. 1974-1978, (1999)

[10]

Lipscomb G.H., Givens V.A., Meyer N.L., Bran D., Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy, Fertil Steril, 81, pp. 1221-1224, (2004)

← 1 2 →